We are at the forefronts of fighting viral diseases that have global pandemic potential, presenting unmet medical needs, and ...
Lenacapavir is a long-acting antiretroviral medicine that has introduced a fundamentally different approach to HIV prevention ...
Small HIV trials suggest combinations of immune therapies may help some people control the virus without daily medication, although larger studies and sustained funding are still needed.
SHELTON, CT / ACCESS Newswire / October 5, 2026 / , Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader ...
Antibody Infusions Kept HIV in Check for Years in Some Patients, Helped by Their Own Immune Defenses
New RIO trial analysis shows two long-acting antibodies let some people with HIV stay off daily treatment for months or years ...
Doctors at San Francisco General Hospital's famed AIDS clinic have shown the immune system can be primed to keep the virus in ...
Around 12 per cent of the world’s total cancer cases in 2024 were likely caused by an infection, according to new research from the World Health Organization (WHO). The study, published last Tuesday ...
A WHO-IARC study has estimated that nearly 1.9 lakh new cancer cases in India each year are attributable to infections. The ...
Developed by United States pharmaceutical company Gilead Sciences, the injectable drug can be used to prevent HIV. “It’s the most innovative tool that has reached the HIV arena for the last decade, ...
For people living with HIV, the road to a promising cancer treatment can be longer than it should be, literally.
Viruses come in two major flavors—not chocolate and vanilla, quips Harvard Medical School structural biologist Stephen ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results